A Phase I Study of Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma.

Trial Profile

A Phase I Study of Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 19 Jul 2011

At a glance

  • Drugs Poly ICLC (Primary)
  • Indications B cell lymphoma; Chronic lymphocytic leukaemia; Follicular lymphoma; Lymphoid leukaemia; T cell lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Jul 2011 Planned end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 19 Jul 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 10 Jan 2011 Additional lead trial investigator (Delva Deauna-Limayo, MD) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top